Please sign in to follow a disease.
Double stitch may keep babies safer: new study on weak cervix
NCT ID NCT05268640
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether placing two stitches instead of one around the cervix during an emergency can help women with a weak cervix carry their pregnancy longer. The trial included 81 women between 16 and 25 weeks of pregnancy whose membranes were bulging out. The goal was to see if the double stitch reduces the number of births before 34 weeks compared to the standard single stitch.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
81 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * singleton pregnancy, * gestational age 16+0 to 25+6 weeks, * live fetus, * cervical incompetence with fetal membranes visible through external os before 24+0 weeks of gestation, * informed written consent. Exclusion Criteria - any of the following occuring before the administration of the cerclage: * preterm premature rupture of membranes, * vaginal bleeding, * active regular uterine contractions, * fetal demise, * fever, * intrauterine infection (diagnosed in case of maternal body temperature ≥ 38°C with no alternative cause identified and at least 2 symptoms among the following appear: fetal tachycardia \> 160 bpm for 10 minutes or longer, uterine pain, purulent vaginal discharge, white blood cell count \> 15 G/L in the absence of corticosteroid treatment or increased plasma C-reactive protein \> 10 mg/L), * known genetic defects of the fetus, * known lethal fetal malformations, * congenital uterine defects, * multiple pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cervical incompetence are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
1st Department of Obstetrics and Gynecology, Center of Postagraduate Medical Education
Warsaw, Masovian Voivodeship, 01-004, Poland
-
1st Department of Obstetrics and Gynecology, Medical University of Warsaw
Warsaw, Masovian Voivodeship, 02-015, Poland
-
Department of Obstetrics and Gynecology, Oncological Gynecology and Gynecological Endocrinology, Medical University of Gdansk
Gdansk, Pomeranian Voivodeship, 80-952, Poland
-
Department of Obstetrics, Perinatology and Neonatology, Center of Postagraduate Medical Education
Warsaw, Masovian Voivodeship, 01-809, Poland
-
Department of Obstetrics, Women's Diseases and Oncological Gynecology, Nicolaus Copernicus University
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-168, Poland
-
Institute of Mother and Child
Warsaw, Poland
-
Polish Mother's Memorial Hospital - Research Institute
Lodz, Łódź Voivodeship, 93-338, Poland